物质信息

ID:176897

名称和标识
IUPAC标准名
(4S)-4-[(2S)-2-[(2S)-2-[(2S)-2-{2-[(2S)-2-(2-{2-[2-(2-{[(2S)-1-[(2S)-2-{[(2S)-1-[(2R)-2-amino-3-phenylpropanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}acetamido)acetamido]acetamido}acetamido)-3-carbamoylpropanamido]acetamido}-3-carboxypropanamido]-3-phenylpropanamido]-4-carboxybutanamido]-4-{[(2S,3S)-1-[(2S)-2-{[(1S)-3-carboxy-1-{[(1S)-3-carboxy-1-{[(1S)-1-{[(1S)-1-carboxy-3-methylbutyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}propyl]carbamoyl}propyl]carbamoyl}pyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]carbamoyl}butanoic acid
IUPAC传统名
bivalirudin
商标名
Angiomax
别名
d-Phenylalanyl-l-prolyl-l-arginyl
-l-prolylglycylglycylglycylglycyl-l-asparaginylglycyl
-l-alpha-aspartyl-l-phenylalanyl
-l-alpha-glutamyl-l-alpha-glutamyl-l-isoleucyl
-l-prolyl-l-alpha-glutamyl-l-alpha-glutamyl
-l-tyrosyl-l-leucine
Bivalirudin
数据登录号
PubChem CID
CHEBI ID
维基百科标题
ATC码
DrugBank ID
美国药典/FDA物质标识码
Chemspider ID
CHEMBL
化合物性质
药理学性质
给药途径
Intravenous injection/infusion only
妊娠期药物分类
B (US)
生物利用度
N/A (IV application only)
代谢
Angiomax is cleared from plasma by a combination of renal mechanisms and proteolytic cleavage
半衰期
~25 minutes in patients with normal renal function
法定药品分级
Rx-only. Not a controlled substance.
描述信息
分子图谱
暂无数据
点击上传数据
参考文献
暂无数据
点击上传数据